Sunday, March 03, 2024 3:05:06 PM
My interpretation (correct or not) is that Lebby made an effort to explain what is going on with the licensing agreement discussions. He brought up three topics that are areas of interest in the due diligence process being conducted by the largest potential customers. He did make the point that they are currently talking with very small interested parties as well. The boxes that need to be checked are different depending on what part of the ecosystem a potential customer sits. A foundry wants to be assured they can get all the Perkinamine they could ever require. They also need to be assured the polymer can maintain its performance level for at least as long as the incumbent technology. After all, if a foundry sells one million transceivers to a hyperscaler’s data center and the transceivers start to fail after a year, who is responsible and what is the corrective course of action. These are due diligence topics.
The foundry needs to understand the economics of producing millions of PICs on their 200mm wafers. This knowledge comes from trial runs and test results. These trials have been ongoing for at least a year with multiple foundries. Some foundries are ahead of others. We know Dr Lebby has been very pleased with the test results on the PICs that have been produced on 200mm wafers. These terrific results need to be verified from run to run from multiple foundries. All of these production statistics are put into formulas to arrive at an agreeable price and royalty arrangement. These are due diligence topics.
The third area about financial stability was really not a concern, in my opinion. I think it was an opportunity for Dr Lebby to reiterate the financial strength of the company. The cash position and shelf offer assurance. Think of it this way from the customer’s viewpoint: “I see your balance sheet today and I am about to give you a $200 million order so should I be concerned if your company will survive long term?”
Dr Lebby gave the shareholders some insight into the topics being discussed currently with major multi-billion dollar potential customers. These topics are rather obvious to me and I think Dr Lebby has anticipated them for years. He has been working with multiple foundries and packaging partners to be ready to address these topics. For the most part, Lightwave Logic is able to check off these boxes today. What remains is all related to continuity of supply.
It doesn’t matter what your motives are for posting on this board or how one wishes to read between the lines, one thing is extremely clear:
The due diligence being conducted by the major players today is all about high volume supply. It doesn’t matter which sales prong gets the order. “They” are interested in tens of millions of transceivers to retrofit their data centers.
Recent LWLG News
- Lightwave Logic Demonstrates Thought Leadership with Critical Contributions to Global Integrated Photonics Industry Roadmap • PR Newswire (US) • 04/16/2024 12:31:00 PM
- Lightwave Logic Secures New Patent for Diamondoid Non-linear Optical Chromophore Patent to Improves Material Robustness • PR Newswire (US) • 04/01/2024 12:31:00 PM
- Lightwave Logic EO Polymer Achieves World-Class Performance of 400Gbps with Plasmonic Mach Zehnder Modulator • PR Newswire (US) • 03/28/2024 12:31:00 PM
- Lightwave Logic Demonstrates World-Class 200Gbps Heterogeneous Polymer/Silicon Photonic Modulator Results • PR Newswire (US) • 03/25/2024 12:31:00 PM
- Lightwave Logic to Host Annual Meeting of Shareholders on May 22, 2024 • PR Newswire (US) • 03/19/2024 12:31:00 PM
- Lightwave Logic to Participate in Upcoming Investor Conferences • PR Newswire (US) • 03/15/2024 12:31:00 PM
- Lightwave Logic Provides Fourth Quarter and Fiscal Year 2023 Corporate Update • PR Newswire (US) • 03/01/2024 01:31:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 10:09:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:00:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/07/2023 12:11:28 AM
- Lightwave Logic Issues Shareholder Letter and Provides Corporate Update • PR Newswire (US) • 12/04/2023 01:31:00 PM
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Lightwave Logic Provides Third Quarter 2023 Corporate Update • PR Newswire (US) • 11/10/2023 01:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:24:23 PM
- Lightwave Logic to Participate in Upcoming Investor Conferences • PR Newswire (US) • 11/06/2023 01:31:00 PM
- Lightwave Logic CEO Dr. Michael Lebby to Present at the Optica Photonic-Enabled Cloud Computing Industry Summit • PR Newswire (US) • 10/12/2023 12:50:00 PM
- Lightwave Logic Receives 2023 Industry Innovation Award for Hybrid PIC/Optical Integration Platform at the European Conference on Optical Communications • PR Newswire (US) • 10/03/2023 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 08:00:08 PM
- Lightwave Logic to Participate in Upcoming Investor Conferences • PR Newswire (US) • 09/05/2023 12:31:00 PM
- Lightwave Logic Expands Its Colorado Operations to Support New Commercial Activities • PR Newswire (US) • 08/21/2023 12:31:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 08:03:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/10/2023 08:01:26 PM
- Lightwave Logic Provides Second Quarter 2023 Corporate Update • PR Newswire (US) • 08/10/2023 12:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:56:47 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM